Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis
Stopped early
Conditions studied: Multiple Sclerosis
In brief
The primary objective is to evaluate the feasibility of the Multiple Sclerosis Performance Test (MSPT) in a clinical care setting when used by participants with Multiple Sclerosis (MS).
Key facts
- Study ID
- NCT03926637
- Run by
- Biogen
- People needed
- 3073
- Starts
- 2019-06-17
- Expected to finish
- 2022-12-05
- Last updated by the study team
- 2023-01-30
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Berkeley, California, United States
- Research Site — Los Angeles, California, United States
- Research Site — Aurora, Colorado, United States
- Research Site — Washington D.C., District of Columbia, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Boston, Massachusetts, United States
- Research Site — Farmington Hills, Michigan, United States
- Research Site — Owosso, Michigan, United States
- Research Site — St Louis, Missouri, United States
- Research Site — Teaneck, New Jersey, United States
- Research Site — Buffalo, New York, United States
- Research Site — Durham, North Carolina, United States
- Research Site — Oklahoma City, Oklahoma, United States
- Research Site — Portland, Oregon, United States
- Research Site — Philadelphia, Pennsylvania, United States
- Research Site — Pittsburgh, Pennsylvania, United States
- Research Site — Dallas, Texas, United States
- Research Site — Salt Lake City, Utah, United States
- Research Site — Seattle, Washington, United States
- Research Site — Spokane, Washington, United States
- Research Site — Prague, Czechia
- Research Site — Strasbourg, France
- Research Site — Bari, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.